Industry M&A volume declined 8% this year compared to '23

Industry M&A volume declined 8% this year compared to '23

Source: 
Fierce Biotech
News Tags: 
snippet: 

Though M&A deal value and volume both declined in biopharma in 2024 compared to the year prior, PwC analysts still believe 2025 will be an active year for the sector.